Log In
BCIQ
Print this Print this
 

cetirizine (AC-170)

  Manage Alerts
Collapse Summary General Information
Company Nicox S.A.
DescriptionTopical formulation of cetirizine, a histamine H1 receptor (HRH1) antagonist
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat allergic conjunctivitis; Treat ocular itching associated with allergic conjunctivitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$120.0M

0

$55.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/27/2014

$120.0M

0

$55.0M

Get a free BioCentury trial today